Joseph C Papa's Net Worth

$74.7 Million

Estimate Recalculated Oct 6, 2025 08:51PM EST

Who is Joseph C Papa

Joseph C Papa has an estimated net worth of $74.7 Million. This is based on reported shares across multiple companies, which include CARDINAL HEALTH INC, Bausch Health Companies Inc., Prometheus Biosciences, Inc., PERRIGO Co plc, PERRIGO CO, Candel Therapeutics, Inc., Bausch & Lomb Corp, WATSON PHARMACEUTICALS INC, Emergent BioSolutions Inc., and Milestone Pharmaceuticals Inc..

SEC CIK

Joseph C Papa's CIK is 0001242215

Past Insider Trading and Trends

2013 was Joseph C Papa's most active year for acquiring shares with 25 total transactions. Joseph C Papa's most active month to acquire stocks was the month of July. 2012 was Joseph C Papa's most active year for disposing of shares, totalling 47 transactions. Joseph C Papa's most active month to dispose stocks was the month of July. 2016 saw Joseph C Papa paying a total of $14,529,432.18 for 3,212,094 shares, this is the most they've acquired in one year. In 2021 Joseph C Papa cashed out on 585,028 shares for a total of $8,755,242.91, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

CARDINAL HEALTH INC

Chmn & CEO, Pharm Techn & Svcs
Updated Dec 15, 2004
Form 4
657.95%
12.50K
Dec 15, 2004
14.40K
Grant
Dec 13
Form 3
Dec 15, 2004
1.90K
Showing 2 results

Bausch Health Companies Inc.

CHAIRMAN & CEO
Updated May 12, 2022
Form 4
30.35%
332.42K
$9.40
-$3.76M
May 12, 2022
1.43M
Options
May 10
Form 4
-1.14%
-12.64K
$23.61
-$298.50K
Mar 07, 2022
1.10M
Tax
Mar 03
Form 4
7.40%
76.38K
$24.35
-$8.28M
Mar 02, 2022
1.11M
Options
Feb 26 - Feb 28
Form 4
-0.82%
-8.56K
$28.88
-$247.18K
Sep 15, 2021
1.03M
Tax
Sep 13 - Sep 14
Form 4
-10.57%
-122.93K
$32.97
-$7.62M
Mar 10, 2021
1.04M
Options
Mar 08 - Mar 10
Form 4
35.07%
270.61K
Mar 05, 2021
1.04M
Grant
Mar 03
Form 4
-3.52%
-28.19K
$31.42
-$885.79K
Mar 03, 2021
771.67K
Tax
Mar 01
Form 4
-1.08%
-8.74K
$15.70
-$137.17K
Sep 16, 2020
799.87K
Tax
Sep 14 - Sep 15
Form 4
-10.56%
-95.49K
$17.16
-$1.64M
May 06, 2020
808.60K
Tax
May 04
Form 4
-2.00%
-18.49K
$20.96
-$387.51K
Mar 11, 2020
904.09K
Tax
Mar 09
Form 4
-1.52%
-14.19K
$23.77
-$337.45K
Mar 03, 2020
922.58K
Tax
Feb 28 - Mar 02
Form 4
49.33%
422.15K
Feb 28, 2020
1.28M
Grant
Feb 26
Form 4
-0.59%
-5.12K
$23.24
-$118.87K
Sep 18, 2019
855.73K
Tax
Sep 16
Form 4
6.33%
51.25K
$23.31
$699.30K
Sep 13, 2019
860.85K
Purchase
Sep 13
Form 4
-2.25%
-18.66K
$23.56
-$439.58K
Mar 12, 2019
809.60K
Tax
Mar 08
Form 4
46.19%
317.37K
Mar 01, 2019
1.00M
Grant
Feb 27
Form 4
8.73%
60.00K
$23.67
$710.10K
Feb 28, 2019
747.08K
Purchase
Feb 28
Form 4
9.57%
60.00K
$22.32
$669.60K
Sep 17, 2018
687.08K
Purchase
Sep 14
Form 4
-12.79%
-91.94K
$18.31
-$1.68M
May 04, 2018
627.08K
Tax
May 03
Form 4
4.35%
30.00K
$16.05
$481.50K
Mar 13, 2018
719.02K
Purchase
Mar 13
Form 4
167.40%
963.14K
Mar 09, 2018
1.54M
Grant
Mar 07
Form 4
39.49%
884.65K
$24.48
$4.94M
Jun 13, 2016
3.12M
Purchase
Jun 09 - Jun 10
Form 4
2.24M
May 04, 2016
2.24M
Grant
May 02
Form 3
May 04, 2016
Showing 24 results

Prometheus Biosciences, Inc.

Investor
Updated Jun 16, 2023
Form 4
-100.00%
-106.99K
Jun 16, 2023
Disposition
Jun 16
Form 4
Jun 02, 2023
17.28K
Acq/Dis
Jun 02
Form 4
15.19%
2.28K
May 19, 2023
17.28K
Grant
May 19
Form 4
22.55K
May 20, 2022
22.55K
Grant
May 19
Form 4
2.17K
Nov 16, 2021
2.17K
Grant
Nov 14
Form 4
15.00K
$19.00
$285.00K
Mar 16, 2021
15.00K
Purchase
Mar 16
Form 3
Mar 11, 2021
Showing 7 results

PERRIGO Co plc

CEO
Updated Mar 01, 2016
Form 4
87.24K
$129.23
$9.58M
Mar 01, 2016
205.76K
Grant
Feb 26
Form 4
-0.62%
-798.00
$102.95
-$898.62K
Dec 30, 2015
128.80K
Sale
ScheduledMar 13 - Dec 28
Form 4
3.58%
4.13K
$186.89
$2.15M
Aug 25, 2015
119.42K
Options
Aug 21
Form 4
21.99K
Jul 01, 2015
129.92K
Grant
Jun 29
Form 4
0.94%
1.01K
$149.22
$1.85M
Aug 26, 2014
107.93K
Options
Aug 22
Form 4
66.72K
$147.75
$7.48M
Aug 25, 2014
162.22K
Grant
Aug 21
Form 4
-9.55%
-11.15K
$108.29
-$988.66K
Mar 26, 2014
105.68K
Sale
ScheduledMar 05 - Mar 24
Form 4
-4.10%
-5.00K
$104.67
-$458.43K
Feb 19, 2014
116.84K
Sale
ScheduledFeb 14
Form 4
-3.94%
-5.00K
$108.21
-$493.86K
Jan 21, 2014
121.84K
Sale
ScheduledJan 16
Form 4
290.77K
Dec 20, 2013
290.77K
Grant
Dec 18
Form 3
Dec 20, 2013
Showing 11 results

PERRIGO CO

President and CEO
Updated Dec 19, 2013
Form 4
-100.00%
-290.77K
Dec 19, 2013
Disposition
Dec 18
Form 4
-21.63%
-35.00K
$99.34
-$1.52M
Dec 16, 2013
126.84K
Sale
ScheduledDec 09 - Dec 12
Form 4
-11.06%
-15.00K
$80.22
-$1.33M
Sep 26, 2013
120.62K
Sale
ScheduledSep 24
Form 4
-1.52%
-1.80K
Sep 13, 2013
116.66K
Grant
Sep 03 - Sep 05
Form 4
-9.84%
-15.00K
$76.75
-$1.23M
Aug 29, 2013
137.42K
Sale
ScheduledAug 27
Form 4
59.55%
64.37K
$119.58
$6.57M
Aug 26, 2013
172.47K
Grant
Aug 22 - Aug 23
Form 4
-6.04%
-6.95K
$118.74
$961.08K
Aug 21, 2013
108.09K
Options
Aug 19
Form 4
-6.95%
-10.00K
$82.20
-$926.86K
Jul 15, 2013
133.96K
Sale
ScheduledJul 11
Form 4
7.46%
10.00K
$77.12
-$825.41K
Jun 18, 2013
143.96K
Sell-Options
ScheduledJun 14
Form 4
-3.15%
-5.00K
$78.18
-$423.32K
May 17, 2013
153.96K
Sale
ScheduledMay 15
Form 4
-9.43%
-10.64K
$74.26
-$1.11M
Apr 11, 2013
102.19K
Sale
ScheduledApr 09
Form 4
-11.73%
-15.00K
$73.19
-$1.59M
Mar 14, 2013
112.83K
Sale
ScheduledMar 12
Form 4
-3.76%
-5.00K
$71.07
-$410.07K
Feb 19, 2013
127.83K
Sale
ScheduledFeb 14
Form 4
-3.63%
-5.00K
$67.28
-$372.19K
Jan 22, 2013
132.83K
Sale
ScheduledJan 17
Form 4
-9.81%
-15.00K
$63.56
-$1.21M
Dec 18, 2012
137.83K
Sale
ScheduledDec 14
Form 4
-11.26%
-15.00K
$65.42
-$1.06M
Nov 19, 2012
118.23K
Sale
ScheduledNov 15
Form 4
-10.12%
-15.00K
$73.72
-$1.31M
Oct 12, 2012
133.23K
Sale
ScheduledOct 10
Form 4
-10.76%
-15.00K
$73.33
-$1.30M
Sep 25, 2012
124.44K
Sale
ScheduledSep 21
Form 4
-22.16%
-36.00K
$64.84
-$886.74K
Sep 04, 2012
126.45K
Sale
ScheduledAug 28 - Aug 30
Form 4
-47.90%
-81.60K
$110.66
-$1.24M
Aug 29, 2012
141.65K
Options
Aug 27
Form 4
52.21K
Aug 27, 2012
152.21K
Grant
Aug 23
Form 4
-7.78%
-10.00K
$68.93
-$920.46K
Jul 20, 2012
118.61K
Sale
ScheduledJul 18
Form 4
-8.44%
-10.00K
$67.71
-$944.22K
Jun 22, 2012
108.44K
Sale
ScheduledJun 20
Form 4
-11.84%
-15.91K
$59.86
-$1.48M
May 23, 2012
118.44K
Sale
ScheduledMay 21
Form 4
-4.22%
-5.00K
$63.55
-$430.47K
Apr 23, 2012
113.54K
Sale
ScheduledApr 19
Form 4
-4.05%
-5.00K
$61.38
-$408.77K
Mar 26, 2012
118.54K
Sale
ScheduledMar 22
Form 4
-3.89%
-5.00K
$56.49
-$372.45K
Feb 24, 2012
123.54K
Sale
ScheduledFeb 22
Form 4
-4.24%
-5.00K
$58.64
-$413.43K
Jan 23, 2012
112.95K
Sale
ScheduledJan 19
Form 4
-8.17%
-10.50K
$58.17
-$817.56K
Jan 03, 2012
117.95K
Sale
ScheduledDec 06 - Dec 29
Form 4/A
-7.30%
-10.00K
$54.97
-$689.29K
Nov 28, 2011
127.00K
Sale
ScheduledNov 22
Form 4
-3.94%
-10.18K
$54.97
-$705.39K
Nov 23, 2011
248.41K
Sale
ScheduledNov 22
Form 4
-5.60%
-10.00K
$59.55
-$781.04K
Oct 26, 2011
168.61K
Sale
ScheduledOct 24
Form 4
-8.24%
-10.00K
$93.25
-$932.54K
Sep 26, 2011
111.41K
Sale
ScheduledSep 22
Form 4
-17.23%
-25.27K
$90.94
$2.23M
Aug 29, 2011
121.41K
Options
Aug 25
Form 4
49.56%
51.21K
$88.34
-$441.71K
Aug 25, 2011
154.55K
Grant
Aug 23 - Aug 24
Form 4
-15.09%
-21.00K
$54.51
-$1.55M
Apr 27, 2011
118.12K
Sale
ScheduledApr 25
Form 4
-15.07%
-21.00K
$47.94
-$1.30M
Mar 24, 2011
118.31K
Sale
ScheduledMar 22
Form 4
-15.48%
-21.70K
$46.14
-$1.32M
Feb 23, 2011
118.51K
Sale
ScheduledFeb 07 - Feb 22
Form 4/A
39.03K
Sep 22, 2010
Grant
Aug 19
Form 4
-10.71%
-14.64K
$57.62
-$688.10K
Sep 01, 2010
122.04K
Options
Aug 30
Form 4
100.53%
81.06K
$58.82
-$1.62M
Aug 23, 2010
161.69K
Grant
Aug 19
Form 4
-20.82%
-21.50K
$28.94
-$465.78K
Nov 30, 2009
81.76K
Sale
Nov 25
Form 4
155.63%
109.56K
$30.06
-$356.42K
Aug 27, 2009
179.96K
Grant
Aug 25
Form 4
-28.71%
-30.00K
$25.17
-$472.49K
Dec 03, 2008
74.48K
Sale
Dec 01 - Dec 02
Form 4
-31.09%
-31.76K
$37.86
-$1.20M
Oct 02, 2008
70.40K
Tax
Oct 01
Form 4
79.77K
Aug 27, 2008
181.93K
Grant
Aug 25
Form 4
-18.46%
-23.12K
$21.66
-$500.80K
Oct 02, 2007
102.15K
Tax
Oct 01
Form 4
133.30K
Sep 04, 2007
258.57K
Grant
Aug 30
Form 4
210.49K
Oct 11, 2006
210.49K
Grant
Oct 09
Form 3
Oct 11, 2006
Showing 50 results

Candel Therapeutics, Inc.

Investor
Updated Jun 27, 2024
Form 4
14.24K
Jun 27, 2024
14.24K
Grant
Jun 26
Form 4
14.24K
Jun 29, 2023
14.24K
Grant
Jun 28
Form 4
38.03K
$1.92
$73.06K
Dec 12, 2022
38.03K
Purchase
Dec 08 - Dec 09
Form 4
28.48K
Aug 10, 2022
28.48K
Grant
Aug 08
Form 3
Aug 10, 2022
Showing 5 results

Bausch & Lomb Corp

CEO & Chairman
Updated May 09, 2022
Form 4
2.34M
May 09, 2022
2.34M
Grant
May 05
Form 3
May 05, 2022
Showing 2 results

WATSON PHARMACEUTICALS INC

Former President & COO
Updated Nov 24, 2004
Form 4
-38.14%
-32.00K
$25.92
-$190.53K
Nov 24, 2004
51.90K
Sale
Nov 22
Form 4
40.00K
Aug 11, 2004
43.90K
Grant
Aug 09
Form 4
40.00K
Dec 09, 2003
42.47K
Grant
Nov 22
Showing 3 results

Emergent BioSolutions Inc.

President and CEO
Updated Mar 15, 2024
Form 4
750.00K
Mar 15, 2024
750.00K
Grant
Mar 13
Form 3
Feb 29, 2024
Showing 2 results

Milestone Pharmaceuticals Inc.

Investor
Updated Sep 05, 2024
Form 4
80.00K
Sep 05, 2024
80.00K
Grant
Sep 03
Form 3
Sep 05, 2024
Showing 2 results